A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis
Authors
Keywords
-
Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 20, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-22
DOI
10.1007/s11882-020-00910-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European Position Paper on Rhinosinusitis and Nasal Polyps 2020
- (2020) W.J. Fokkens et al. RHINOLOGY
- Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
- (2019) Sarah Faiz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Rationing of Health Care in the United States
- (2019) Howard Bauchner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-effectiveness and comparative effectiveness of biologic therapy for asthma
- (2019) William C. Anderson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps
- (2019) Christopher D. Codispoti et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- A new treatment for chronic rhinosinusitis with nasal polyps
- (2019) Whitney W Stevens LANCET
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art
- (2019) Lei Ren et al. World Allergy Organization Journal
- Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps
- (2019) Noriko Ogasawara et al. Mucosal Immunology
- Proposals to Redesign Medicare Part D — Easing the Burden of Rising Drug Prices
- (2019) Stacie B. Dusetzina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
- (2019) Takanori Numata et al. BMC Pulmonary Medicine
- Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions
- (2018) Kristine A. Smith et al. American Journal of Rhinology & Allergy
- Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
- (2018) Zuzhen Ou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A Cost-Effectiveness Analysis of Reslizumab in the Treatment of Poorly Controlled Eosinophilic Asthma
- (2018) Jenny Lam et al. JOURNAL OF ASTHMA
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations
- (2018) R. Brett McQueen et al. PHARMACOECONOMICS
- Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement
- (2018) Minal R. Patel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
- (2018) Alison G. Kartush et al. American Journal of Rhinology & Allergy
- Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016
- (2018) Scott D. Grosse et al. PEDIATRIC PULMONOLOGY
- Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
- (2017) Carlos Iribarren et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
- (2017) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry
- (2017) David Fiorentino et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps
- (2017) Claus Bachert et al. Journal of Allergy and Clinical Immunology-In Practice
- Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis
- (2016) George A. Scangas et al. LARYNGOSCOPE
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
- (2014) Aidan Long et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis
- (2014) Luke Rudmik et al. LARYNGOSCOPE
- Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
- (2012) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
- (2011) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- (2008) Scott D Grosse Expert Review of Pharmacoeconomics & Outcomes Research
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started